These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

493 related items for PubMed ID: 11254842

  • 1. Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.
    Kojima T, Gando S, Kemmotsu O, Mashio H, Goda Y, Kawahigashi H, Watanabe N.
    J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):60-4. PubMed ID: 11254842
    [Abstract] [Full Text] [Related]

  • 2. Tissue factor is rapidly elevated in plasma collected from the pericardial cavity during cardiopulmonary bypass.
    Philippou H, Adami A, Davidson SJ, Pepper JR, Burman JF, Lane DA.
    Thromb Haemost; 2000 Jul; 84(1):124-8. PubMed ID: 10928482
    [Abstract] [Full Text] [Related]

  • 3. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P, Kuitunen A, Petäjä J, Ilveskero S, Lassila R.
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [Abstract] [Full Text] [Related]

  • 4. Early heparin administration attenuates tissue factor-mediated thrombin generation during simulated cardiopulmonary bypass.
    Morizumi S, Hiramatsu Y, Matsuzaki K, Goto Y, Sato S, Abe M, Kato H, Matsubara M, Sakakibara Y.
    J Card Surg; 2014 Jan; 29(1):35-40. PubMed ID: 24266905
    [Abstract] [Full Text] [Related]

  • 5. Involvement of tissue factor pathway inhibitor in the coronary circulation of patients with acute coronary syndromes.
    Golino P, Ravera A, Ragni M, Cirillo P, Piro O, Chiariello M.
    Circulation; 2003 Dec 09; 108(23):2864-9. PubMed ID: 14656922
    [Abstract] [Full Text] [Related]

  • 6. Cardiopulmonary bypass parameters and hemostatic response to cardiopulmonary bypass in infants versus children.
    Eisses MJ, Chandler WL.
    J Cardiothorac Vasc Anesth; 2008 Feb 09; 22(1):53-9. PubMed ID: 18249331
    [Abstract] [Full Text] [Related]

  • 7. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
    Despotis GJ, Joist JH.
    J Cardiothorac Vasc Anesth; 1999 Aug 09; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
    [Abstract] [Full Text] [Related]

  • 8. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
    Falciani M, Gori AM, Fedi S, Chiarugi L, Simonetti I, Dabizzi RP, Prisco D, Pepe G, Abbate R, Gensini GF, Neri Serneri GG.
    Thromb Haemost; 1998 Mar 09; 79(3):495-9. PubMed ID: 9531029
    [Abstract] [Full Text] [Related]

  • 9. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.
    Lizakowski S, Zdrojewski Z, Jagodzinski P, Rutkowski B.
    Scand J Urol Nephrol; 2007 Mar 09; 41(3):237-42. PubMed ID: 17469034
    [Abstract] [Full Text] [Related]

  • 10. Management of heparin resistance during cardiopulmonary bypass: the effect of five different anticoagulation strategies on hemostatic activation.
    Koster A, Fischer T, Gruendel M, Mappes A, Kuebler WM, Bauer M, Kuppe H.
    J Cardiothorac Vasc Anesth; 2003 Apr 09; 17(2):171-5. PubMed ID: 12698397
    [Abstract] [Full Text] [Related]

  • 11. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant?
    Brister SJ, Ofosu FA, Buchanan MR.
    Thromb Haemost; 1993 Aug 02; 70(2):259-62. PubMed ID: 8236131
    [Abstract] [Full Text] [Related]

  • 12. Plasma free tissue factor pathway inhibitor (TFPI) levels and TF-induced thrombin generation ex vivo in men with low testosterone levels.
    Agledahl I, Brodin E, Svartberg J, Hansen JB.
    Thromb Haemost; 2009 Mar 02; 101(3):471-7. PubMed ID: 19277407
    [Abstract] [Full Text] [Related]

  • 13. Acute release of tissue factor pathway inhibitor after in vivo thrombin generation in baboons.
    Lupu C, Kruithof EK, Kakkar VV, Lupu F.
    Thromb Haemost; 1999 Dec 02; 82(6):1652-8. PubMed ID: 10613651
    [Abstract] [Full Text] [Related]

  • 14. Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds.
    Hattori T, Khan MM, Colman RW, Edmunds LH.
    J Am Coll Cardiol; 2005 Aug 16; 46(4):707-13. PubMed ID: 16098440
    [Abstract] [Full Text] [Related]

  • 15. Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F1 + 2.
    Boisclair MD, Lane DA, Philippou H, Sheikh S, Hunt B.
    Thromb Haemost; 1993 Aug 02; 70(2):253-8. PubMed ID: 8236130
    [Abstract] [Full Text] [Related]

  • 16. Atorvastatin reduces thrombin generation after percutaneous coronary intervention independent of soluble tissue factor.
    Bartok A, Steiner S, Seidinger D, Jetzl A, Huber K, Minar E, Stefenelli T, Kopp CW.
    Thromb Res; 2005 Aug 02; 115(6):469-74. PubMed ID: 15792677
    [Abstract] [Full Text] [Related]

  • 17. The impact of cardiac ischemia and reperfusion on markers of activated haemostasis and fibrinolysis during cardiopulmonary bypass: comparison of plasma levels in arterial and coronary venous blood.
    Kalweit G, Bach J, Huwer H, Winning J, Hellstern P.
    Thromb Res; 2005 Aug 02; 116(1):33-9. PubMed ID: 15850606
    [Abstract] [Full Text] [Related]

  • 18. Increased tissue factor pathway inhibitor (TFPI) and coagulation in patients with insulin-dependent diabetes mellitus.
    Leurs PB, van Oerle R, Wolffenbuttel BH, Hamulyak K.
    Thromb Haemost; 1997 Mar 02; 77(3):472-6. PubMed ID: 9065996
    [Abstract] [Full Text] [Related]

  • 19. Impact of long-term testosterone treatment on plasma levels of free TFPI and TF-induced thrombin generation ex vivo in elderly men with low testosterone levels.
    Agledahl I, Brodin E, Svartberg J, Hansen JB.
    Thromb Haemost; 2009 Nov 02; 102(5):945-50. PubMed ID: 19888533
    [Abstract] [Full Text] [Related]

  • 20. The effects of tissue factor pathway inhibitor and anti-beta-2-glycoprotein-I IgG on thrombin generation.
    Lean SY, Ellery P, Ivey L, Thom J, Oostryck R, Leahy M, Baker R, Adams M.
    Haematologica; 2006 Oct 02; 91(10):1360-6. PubMed ID: 17018385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.